Minghui Shi

Minghui Shi

Auto-generated profile, based on publicly available information

Minghui Shi

Xinjiang Institute of Chinese Materia Medica and Ethnodrug, Urumqi, 830011, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LPLan Pan
Lan Pan
TZTao Zhang
Tao Zhang
MYMeng Yu
Meng Yu
MSMinghui Shi
Minghui Shi
XJXinyue Jia
Xinyue Jia
ZZZhong-Mei Zou
Zhong-Mei Zou

25 September 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JWJunchi Wang
Junchi Wang
QZQi Zheng
Qi Zheng
MSMinghui Shi
Minghui Shi
HWHuaxiang Wang
Huaxiang Wang
FZFan Zhao
Fan Zhao
JSJianyong Si
Jianyong Si
Ferula sinkiangensis K. M. Shen (Apiaceae) is distributed in arid desert areas of Xinjiang, and its resin is a traditional Chinese medicine to treat gastrointestinal digestive diseases. To explore bioactive components from F. sinkiangensis, three new lignans and thirteen known components were isolated. The structural elucidation of the components was established utilizing spectroscopic analyses together with ECD calculations. Griess reaction results indicated new compounds 1 and 2 significantly decreased NO production in LPS-stimulated RAW 264.7 macrophages, and ELISA results indicated that they effectively attenuated LPS-induced inflammation by inhibiting TNF-α, IL-1β, and IL-6 expressions. The in silico approach confirmed that compound 1 docked into the receptors with strong binding energies of −5.84~−10.79 kcal/mol. In addition, compound 6 inhibited the proliferation of AGS gastric cancer cells with IC50 values of 15.2 μM by suppressing the cell migration and invasion. This study disclosed that F. sinkiangensis might be a promising potential resource for bioactive components.

1 October 2024 in Heliyon
Verified
Journal Article
Open access
XAXiatiguli Abulizi
Xiatiguli Abulizi
MSMing-Hui Shi
Ming-Hui Shi
YJYue-Mei Jia
Yue-Mei Jia
LXLei Xu
Lei Xu
LSLei-Ling Shi
Lei-Ling Shi
LPLan Pan
Lan Pan
Fruits of Elaeagnus angustifolia L. have been used as Uyghur medicine due to the properties of treating spleen and stomach weakness, indigestion, enteritis, diarrhea, lung heat, and cough. However, the anti-diarrhea mechanism was still not clear. This study explored the mechanism of E. angustifolia fruit alleviated diarrhea from the perspective of gut microbiota. Diarrhea model was established with Folium sennae in mice. Then, the levels of diarrhea rate and diarrhea index of mice were evaluated. Hematoxylin eosin (HE) staining was employed to detect pathological sections of colon tissue. 16S rRNA sequencing analysis was researched to confirm the gut microbiota in mice. Diversity and differential analysis were adopted to analyze the intestinal microflora. Furthermore, Gas chromatography-quadrupole time-of-flight tandem mass spectrometry (GC-Q-TOF-MS) was used to detect the concentrations of short chain fatty acids (SCFAs) in intestine. The high-dose group (3.2 g/kg) of E. angustifolia fruit could significantly reduce the diarrhea rate and diarrhea index of mice caused by Folium sennae (p < 0.01). We also found that E. angustifolia fruit enhanced the diversity of gut microbiota while ameliorating diarrhea. Alpha diversity revealed that the microbial composition of E. angustifolia fruit group tended to be more similar to that of the CON group (no significant difference at p < 0.05). E. angustifolia fruit also induced structural changes of gut microbiota in mice. In addition, the concentrations of SCFAs increased after administration of E. angustifolia fruit. This study demonstrated that E. angustifolia fruit could ameliorate diarrhea by regulating the composition and abundance of intestinal microbiota, together with the levels of SCFAs.